Previous close | 8.74 |
Open | 8.70 |
Bid | 8.53 x 0 |
Ask | 8.90 x 0 |
Day's range | 8.67 - 8.70 |
52-week range | 8.49 - 12.96 |
Volume | |
Avg. volume | 38,856 |
Market cap | 1.595B |
Beta (5Y monthly) | 0.36 |
PE ratio (TTM) | 54.50 |
EPS (TTM) | 0.16 |
Earnings date | N/A |
Forward dividend & yield | 0.19 (2.15%) |
Ex-dividend date | 13 May 2022 |
1y target est | N/A |
BARCELONA, Spain, February 20, 2023--Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, has announced its full-year 2022 financial results today.
BARCELONA, Spain, January 04, 2023--Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, USA from 9-12 January 2023.
BARCELONA, Spain, November 28, 2022--Almirall, S.A. (ALM), a global biopharmaceutical company focused on skin health, today announced that it is participating in FACILITATE, (FrAmework for ClInicaL trIal participants’ daTA reutilization for a fully Transparent and Ethical ecosystem) a patient-driven Innovative Medicines Initiative (IMI) project aimed to create a framework for access and reutilization of clinical trial participant data for a fully compliant and ethical ecosystem. FACILITATE main